Best Practices for Implementing Dual Endothelin Angiotensin Receptor Antagonist Therapeutics in Patients with IgAN
0.50
Already have an Account? Log In
Don’t have an account? Register Today
Recent Courses
Rheumatology
The Evolving Science of Tyrosine Kinase 2 (TYK2) Inhibitors to Improve Outcomes in Patient...
Neurology
Novel Therapeutic Approaches to Multiple Sclerosis: BTK and Second-Generation Anti-CD40 Th...